The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristics.

Hamed Samavat,Allison M Dostal,Renwei Wang,Sarah Bedell,Tim H. Emory,Giske Ursin,Carolyn J. Torkelson,Myron D. Gross,Chap T. Le,Mimi C. Yu,Chung S. Yang,Douglas Yee,Anna H. Wu,Jian-Min Yuan,Mindy S. Kurzer

The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristics.

2015

Hamed Samavat
Allison M Dostal
Renwei Wang
Sarah Bedell
Tim H. Emory
Giske Ursin
Carolyn J. Torkelson
Myron D. Gross
Chap T. Le
Mimi C. Yu
Chung S. Yang
Douglas Yee
Anna H. Wu
Jian-Min Yuan
Mindy S. Kurzer

Purpose The Minnesota Green Tea Trial (MGTT) was a randomized, placebo-controlled, double-blinded trial investigating the effect of daily green tea extract consumption for 12 months on biomarkers of breast cancer risk.

Keywords:

Breast cancer
Green tea extract
Gynecology
Randomized controlled trial
MAMMOGRAPHIC DENSITY
Diabetes mellitus
Biomarker (medicine)
Medicine
postmenopausal women
Gonadal Steroid Hormones
green tea

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations